Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

You can say I told you so. Still the pps is much closer to a $20 handle than it is to a $50 and we've seen this movie before. The stock is bouncing from the low $30s to the low $40s and can't break out back to the highs. This won't change until Helen delivers some substantial new partnerships to prove that this company has the ability to fend off the competition. If she does not in a reasonably short period of time the doubts will re-surface and the pps will start to sag once more.